US equities |
MU $1,085.55 ▲+3.82% NVDA $237.81 ▼-0.60% SNDK $1,695.53 ▲+2.11% SPCX $167.48 ▼-2.58% AMD $647.27 ▼-0.33% TSLA $378.11 ▼-0.68% INTC $113.02 ▲+0.46% AAPL $336.50 ▲+0.86%
FinancialContent

STAAR Surgical Company - Common Stock (NQ:STAA)

22.36 +0.21 (+0.95%)
Delayed Quote Updated: 3:56 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Reports Second Quarter 2026 Results
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical to Host Second Quarter 2026 Earnings Results Call and Webcast on August 12, 2026
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Announces Participation in Upcoming Investor Conferences
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical to Host First Quarter 2026 Earnings Results Call and Webcast on May 13, 2026
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2026
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Issues Shareholder Letter
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
From STAAR Surgical Company
Via Business Wire
News headline image
FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
From STAAR Surgical Company
Via Business Wire
News headline image
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
From Broadwood Partners, L.P.
Via Business Wire
News headline image
STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
From STAAR Surgical Company
Via Business Wire
News headline image
Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
From Yunqi Capital Limited
Via Business Wire
News headline image
Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
From Broadwood Partners, L.P.
Via Business Wire
News headline image
Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger
From STAAR Surgical Company
Via Business Wire
News headline image
Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation “AGAINST” STAAR Surgical Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >